We might not have time to stop and smell a rose, but a candle? Now we’re talking. However, that might not be the case anymore as households face the pressures of rising prices. People would rather plug their noses than invest in fragrances, as home fragrance company dusk’s (ASX: DSK) results for the first half of FY23 reveal.
Read More
Despite aggressive marketing strategies and advertising, premium food business Maggie Beer (ASX: MBH) failed to catch people’s fancy in H1 FY23 as its net sales fell 4.5% to $49.9 million. While retail did okay, its online segment struggled to keep up.
Read More
Fancy $100 million dollar lounges, free high-speed WiFi, new business class suites—the Qantas Group (ASX: QAN) is flexing every muscle to bring customers back after a three-year lull. It looks like it’s working. Even as airfares have increased by about 20%, people are on a post-Covid travel high, helping Qantas rake in the dough. In
Read More
Clinical trials are an essential part of the drug development process and play a critical role in determining the safety and efficacy of new treatments. However, understanding how clinical trials operate can be one of the more difficult concepts to grasp for investors when looking to invest in medical research, drug or device development in
Read More
ASX-listed semiconductor company Archer Materials (ASX: AXE) has increased its global presence as an industry leader, joining the Academia-Industry Collaboration Program, with a team to be based in Switzerland.
Read More
They say diamonds are a girl’s best friend, but higher cost of living and slower growth in discretionary income might hinder young Australians into spending so much on high-ticket fine jewelleries. Instead, they have been seeking alternatives in affordable fashion jewelleries that of course, require far less commitment than buying real diamonds. For fashion jewellery
Read More